Sponsor or institution
Clinical trials and research at Shenyang Sunshine Pharmaceutical Co., LTD.
As of November 12, 2026, Find a Trial lists 13 clinical trials run by Shenyang Sunshine Pharmaceutical Co., LTD. that are recruiting, at sites in 2 countries (most in China (12), Australia (1)). By phase: Phase 1 (7), Phase 2 (4), Phase 3 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 13Clinical trials
- 2Countries
Newest trials
All recruiting trials (13)
-
SSGJ-612 plus a HER2-targeted ADC in HR-positive, HER2-low metastatic breast cancer
This phase II study tests whether adding SSGJ-612 to a HER2-targeted antibody-drug conjugate helps people with HR-positive, HER2-low or ultralow metastatic breast cancer.
-
Test a combination of SSGJ-705 and SSGJ-612 (with or without chemotherapy) in advanced HER2-expressing solid cancers
This phase 2 study tests whether SSGJ-705 plus SSGJ-612, with or without chemotherapy, can help adults with advanced HER2-expressing solid tumors like colorectal, urothelial, breast, gastric, or biliary cancers.
-
SSGJ-706 alone and combined with chemotherapy or PD-1 inhibitors for advanced non-small cell lung cancer
This trial tests whether SSGJ-706 by itself or with chemotherapy and a PD-1 inhibitor can help adults with first-line advanced non-small cell lung cancer.
-
SSS55 safety and how the body handles it in healthy adults
This trial tests a single injection of SSS55 in healthy adults to see if it is safe, how the body processes it, and whether it triggers immune responses.
-
SPGL008 given by IV or under-the-skin injection for advanced malignant tumors
This trial will test whether SPGL008 given intravenously or under the skin is safe and shows early signs of benefit in adults with advanced malignant tumors.
-
Phase 1 SSGJ-612 for advanced HER2‑positive solid tumors
This trial will test SSGJ-612, a new drug, in adults with advanced HER2‑expressing solid tumors who have exhausted standard treatments.
-
SSGJ-705 alone and with chemotherapy for advanced HER2-positive cancers
This trial tests whether SSGJ-705, by itself or combined with chemotherapy (and in some arms with a PD‑1/L1 blocker), can help adults with advanced HER2-positive lung, breast, or stomach cancers.
-
SSGJ-709 for people with advanced malignant tumors
This clinical trial will try SSGJ-709, an experimental intravenous drug given every three weeks, in people with advanced malignant tumors who have exhausted or cannot receive standard treatments to see if it is safe and shows anti-tumor activity.
-
SSS40 injection for moderate-to-severe bone metastatic cancer pain
This trial will test whether SSS40, a humanized NGF antibody injection, can reduce moderate-to-severe pain from bone metastases in adults.
-
HBT-708 for people with advanced solid tumors
This trial will test whether HBT-708 given intravenously every three weeks is safe, tolerable, and might help people with advanced solid tumors.
-
SSGJ-707 versus pembrolizumab for advanced non-small cell lung cancer
This Phase III test will see if SSGJ-707 works as well as or better than pembrolizumab for adults with stage IIIB/IIIC (not suitable for radical therapy) or stage IV non-small cell lung cancer whose tumors have PD-L1 TPS ≥1% and who have ECOG performance status 0–1 and no prior systemic therapy.
-
Testing SSS59 for advanced malignant tumors
This study is testing a new treatment called SSS59 to see if it is safe and effective for people with advanced cancer.
-
Evaluating the safety and effects of SSS11 in patients with gout and high uric acid levels
This study is testing a new treatment called SSS11 to see if it can safely lower uric acid levels in people with gout.
Quick answers
How many clinical trials run by Shenyang Sunshine Pharmaceutical Co., LTD. are recruiting right now?
13, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (12 trials), Australia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 7, Phase 2: 4, Phase 3: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.